Clinical trial
Real-world Safety and Efficacy Data of Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease: the Experience of the Hellenic Cooperative Oncology Group
NCT04805099 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Safety and Efficacy Data of Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease: the Experience of the Hellenic Cooperative Oncology Group
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2020
- Completion date
- February 28, 2021
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune diseases, checkpoint inhibitor, immunotherapy